14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.748 2 days ( 7.28 % )
Last Price $0.683 -7.28 %
High/ Low $0.680 - $0.749 7.21%
Chg 7 Days -4.20 % $0.713 $0.683
Chg 30 Days -82.98 % $4.01 $0.683
Chg 12 mos -66.04 % $2.01 $0.683
Trend - 3 mos 56.58 % Width: 1,097.12 %
Trend - 12 mos 7.51 % Width: 3,327.94 %
Pred. range - 3 mos $1.07 - $12.79 56.58 % - 1,774.40 %
Pred. range - 12 mos $0.209 - $7.16 -69.39 % - 949.19 %
Short MA avg 3 mos Buy Mar 27, 2024 - 20 days
Long MA avg 3 mos Sell Apr 09, 2024 - 12 days
Short/Long MA avg 3 mos Sell Apr 10, 2024 - 11 days
Short MA avg 12 mos Sell Apr 01, 2024 - 18 days
Long MA avg 12 mos Sell Apr 10, 2024 - 11 days
Short/Long MA avg 12 mos Buy Mar 05, 2024 - 36 days
Pivot Short Sell Mar 07, 2024 - 34 days
Bollinger Buy Feb 29, 2024 - 39 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Aptevo Therapeutics Inc

Aptevo Therapeutics Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational ... APVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT